Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson–Gilford progeria syndrome fibroblasts
Bikkul, Mehmet U., Clements, Craig S., Godwin, Lauren S., Goldberg, Martin W., Kill, Ian R., Bridger, Joanna M.Language:
english
Journal:
Biogerontology
DOI:
10.1007/s10522-018-9758-4
Date:
June, 2018
File:
PDF, 1.89 MB
english, 2018